GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2560.05 16.65 (0.65%) | NSE 2559.20 14.90 (0.59%) | Trade | Add

BSE Live

Dec 09, 16:01

2560.05 16.65 (0.65%)

Volume

AVERAGE VOLUME

5-Day

6,126

10-Day

4,123

30-Day

3,709

21,449

Prev. Close

2543.40
Open Price

2527.00

Bid Price (Qty.)
2560.05 (1)
Offer Price (Qty.)
2570.00 (5)

NSE Live

Dec 09, 15:56

2559.20 14.90 (0.59%)

Volume

AVERAGE VOLUME

5-Day

110,938

10-Day

94,565

30-Day

97,086

118,147

Prev. Close

2544.30
Open Price

2534.30

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2559.20 (81)

Financials

Print/Copy to Excel : Go

Profit & Loss account of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	3,689.59	3,385.94	3,181.40	3,190.08	2,886.42
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	3,689.59	3,385.94	3,181.40	3,190.08	2,886.42
Total Operating Revenues	3,723.49	3,407.25	3,216.34	3,217.51	2,920.48
Other Income	142.56	123.48	101.51	76.22	110.19
Total Revenue	3,866.05	3,530.73	3,317.86	3,293.72	3,030.66
EXPENSES
Cost Of Materials Consumed	470.86	504.99	394.35	552.47	452.40
Purchase Of Stock-In Trade	845.11	853.08	788.43	729.44	823.09
Operating And Direct Expenses	0.00	0.00	73.85	93.46	81.96
Changes In Inventories Of FG,WIP And Stock-In Trade	51.23	-69.64	67.25	13.83	-26.12
Employee Benefit Expenses	579.70	624.39	594.99	610.23	616.16
Finance Costs	1.31	1.80	1.81	1.99	3.53
Depreciation And Amortisation Expenses	66.79	69.68	65.77	68.19	78.60
Other Expenses	607.30	593.78	498.06	462.25	375.21
Total Expenses	2,622.31	2,578.08	2,484.50	2,531.86	2,404.84
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,243.74	952.65	833.36	761.87	625.83
Exceptional Items	4.69	-143.62	-0.97	11.58	-172.60
Profit/Loss Before Tax	1,248.44	809.04	832.39	773.44	453.23
Tax Expenses-Continued Operations
Current Tax	323.18	235.71	246.05	219.43	158.67
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	6.20	-11.36	-18.37	-10.49	7.87
Tax For Earlier Years	0.00	0.00	0.00	187.94	0.00
Total Tax Expenses	329.39	224.35	227.69	396.87	166.54
Profit/Loss After Tax And Before ExtraOrdinary Items	919.05	584.69	604.71	376.58	286.69
Profit/Loss From Continuing Operations	919.05	584.69	604.71	376.58	286.69
Profit/Loss For The Period	919.05	584.69	607.75	1,690.53	357.57
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	54.01	40.83	35.90	99.05	31.32
Diluted EPS (Rs.)	54.24	34.51	35.88	99.79	21.11
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	745.39	542.10	1,524.66	508.22	677.62
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	540.00	320.00	320.00	900.00	300.00